SF3B1 was found to be the second most frequently mutated gene in chronic lymphocytic leukemia (CLL) at 5–15%; SF3B1 mutations are less common in the early stages of CLL and become more prevalent in advanced disease where they tend to be associated with poor prognosis. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.